PharVision Advisers’s AMN Healthcare AMN Stock Holding History

PharVision Advisers’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,817	Closed	-$570K	–	276
2024 Q4	$570K	Buy	+23,817	New	+$757K	0.48%	26

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's AMN Position: Q1 2025 in Review

PharVision Advisers sold out of AMN Healthcare (AMN) in Q1 2025, closing a stake of 23,817 shares — an estimated $570K sold.

PharVision Advisers first reported a position in AMN in Q4 2024 and held it in 1 quarter. The position peaked at $570K in Q4 2024. 292 funds tracked by Wall St. Rank hold AMN as of Q1 2025.

PharVision Advisers reported no remaining AMN Healthcare position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 23,817 AMN Healthcare shares in Q1 2025, an estimated $570K.
PharVision Advisers first reported a position in AMN Healthcare in Q4 2024 and held it in 1 quarter.
PharVision Advisers's AMN Healthcare position peaked at $570K in Q4 2024.
292 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.